Consumers Must Make Informed Decisions Regarding Cannabinoids
On January 9, 2023, CONQUER Magazine published a piece written by CUSP’s chairman explaining the legal status of marijuana, CBD,
There Is Another Drug Reform Bill the Senate Must Pass
In this Pain News Network column, CUSP’s chairman urges the U.S. Senate to pass S. 3257, a federal bill to
Journal Seeks Articles on Innovative Opioid Policies
The Journal of Opioid Management (JOM) issued a call for papers for its upcoming special issue, “Legal, Legislative, and Regulatory
House-Passed MOUD Bill Needs Senate Approval
S.3257 Would Ease Restriction on Injectable Buprenorphine A bill passed in the U.S. House of Representatives and introduced in Senate
Following Ruan Decision, DOJ Drops Controlled Substance Case
Shortly after the U.S. Supreme Court’s recent decision in Ruan v. United States, which held that criminal liability under the Controlled
Individual Stories Underlie Addiction
In this review of the Hulu series Dopesick, CUSP Senior Fellow Lynn R. Webster, M.D., and journalist Hazel Shahgholi discuss
Statement on Supreme Court Decision in Ruan v. U.S.
June 27, 2022 – Washington, DC – Today, the Center for U.S. Policy published the following statement in response to
The Supreme Court Is About To Affect Every Prescriber in America
In their Journal of Opioid Management op-ed, Center for U.S. Policy Senior Fellow Lynn Webster, M.D.; Ronald W. Chapman II,
New Resources Educate Decision Makers on Insurance Coverage of Rx Digital Therapies
WASHINGTON, March 28, 2022 /PRNewswire/ -- On Tuesday, March 29, at 1 p.m. ET, Aimed Alliance will host a free
